Related Experiment Video
Updated: Jul 11, 2026
12:18
Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA
Published on: February 9, 2011
23.1K
Sanguinarine-induced proteomic changes in methicillin-resistant Staphylococcus aureus
Xiaolong Zhu1, Pei Zhao2, Lu Jiang2
1Department of Cardiovascular Surgery, Tianjin Chest Hospital, Tianjin University, Tianjin, China.
Summary
Sanguinarine shows strong antibacterial effects against methicillin-resistant Staphylococcus aureus (MRSA). Proteomic analysis reveals it disrupts essential bacterial processes, indicating potential for new antibiotic development against resistant infections.
Area of Science:
- Microbiology
- Biochemistry
- Pharmacology
Background:
- Rising threat of antibiotic-resistant bacteria like methicillin-resistant Staphylococcus aureus (MRSA).
- Decreasing effectiveness of current antibiotic treatments necessitates novel antimicrobial agents.
Purpose of the Study:
- To investigate the antibacterial activity of sanguinarine against MRSA.
- To elucidate the molecular mechanisms of sanguinarine's action using time-resolved proteomics.
Main Methods:
- Minimum Inhibitory Concentration (MIC) determination for sanguinarine against MRSA.
- Comprehensive, time-resolved proteomic analysis of MRSA exposed to sanguinarine over 120 minutes.
- Fuzzy C-means clustering to identify temporal protein expression patterns.
Main Results:
- Sanguinarine demonstrated potent activity against MRSA with an MIC of 20 mg/L.
- Proteomic analysis identified significant alterations in 1,037 proteins over time.
- Upregulated proteins involved in DNA repair and metabolism; downregulated proteins in cell division, iron acquisition, and protein synthesis.
Conclusions:
- Sanguinarine exhibits multifaceted antibacterial effects by disrupting key bacterial functions.
- Sanguinarine shows promise as a lead compound for developing new therapeutics against drug-resistant bacteria.
Related Concept Videos
01:29Staphylococcal Skin Infections
Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
01:25Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
01:25Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...